scholarly journals Approach to knee osteoarthritis in the primary care with current guidelines

2021 ◽  
Vol 21 (2) ◽  
pp. 304-316
Author(s):  
Metin Çelik ◽  
Songül Taştan Çelik ◽  
Burcu Kayhan Tetik
2017 ◽  
Vol 25 ◽  
pp. S204
Author(s):  
M. Herrero ◽  
S. Gimenez ◽  
J. Vergara ◽  
E. Viles ◽  
H. Martinez ◽  
...  

2019 ◽  
Vol 71 (2) ◽  
pp. 189-197 ◽  
Author(s):  
Esther Waugh ◽  
Lauren King ◽  
Natasha Gakhal ◽  
Gillian Hawker ◽  
Fiona Webster ◽  
...  

2008 ◽  
pp. 194-197
Author(s):  
Daniel Paul Bopf ◽  
Michael McAuliffe ◽  
Mark Shillington ◽  
David Drynan ◽  
Emma Bucknell

2008 ◽  
Vol 64 (5) ◽  
pp. 461-467 ◽  
Author(s):  
John Axford ◽  
Christine Heron ◽  
Fiona Ross ◽  
Christina R. Victor

2006 ◽  
Vol 14 ◽  
pp. S171
Author(s):  
M. Acasuso-Diaz ◽  
J. Vidal-Lorenzo ◽  
F. Galdo

2020 ◽  
Vol 72 (10) ◽  
pp. 1358-1366 ◽  
Author(s):  
David Spitaels ◽  
Patrik Vankrunkelsven ◽  
Lies Grypdonck ◽  
Frank-Robberecht Dusar ◽  
Bert Aertgeerts ◽  
...  

2017 ◽  
Vol 8 (2) ◽  
pp. 72-75
Author(s):  
Mike Mulcahy

Since 2003, the dental profession has been challenged by the introduction of drugs, such as bisphosphonates, designed to protect bone mass in the face of pathological and physiological disease changes, including osteoporosis, Paget’s disease and metastatic malignancies. These conditions change the normal dynamic restructuring of bones by osteoblasts and osteoclasts, resulting in less bone resorption by osteoclasts. 1 However, they are also associated with osteonecrosis and current guidelines are inconsistent as to whether antibiotics should be used prophylactically. We present the results of a survey of the advice oral surgeons would give to PDCPs treating patients receiving bisphosphonates, and discuss the implications for patient care.


Sign in / Sign up

Export Citation Format

Share Document